The ratio of TIL CD4+ and CD8+ T cells in the brain as well as bone marrow was evaluated three weeks after tumor implantation in untreated, systemic-treated, and combined-treated glioma-bearing mice to assess the effect of Tregs depletion on the expansion of CD8+ T cells infiltrating the glioma. The gene discussed is CD4; the disease is central nervous system cancer.